RA
Royce & Associates Portfolio holdings
AUM
$9.74B
1-Year Return
15.99%
This Quarter Return
-7.72%
1 Year Return
+15.99%
3 Year Return
+81.23%
5 Year Return
+192.6%
10 Year Return
+438.14%
AUM
$9.23B
AUM Growth
-$1.55B
(-14%)
Cap. Flow
-$502M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
9.23%
Holding
885
New
56
Increased
314
Reduced
330
Closed
89
Top Buys
| 1 |
FTAI Aviation
FTAI
|
+$22.6M |
| 2 |
Franklin Covey
FC
|
+$22M |
| 3 |
Vestis
VSTS
|
+$18.6M |
| 4 |
Walker & Dunlop
WD
|
+$17.4M |
| 5 |
Metropolitan Bank Holding Corp
MCB
|
+$15.6M |
Top Sells
| 1 |
Ziff Davis
ZD
|
+$31.5M |
| 2 |
Shutterstock
SSTK
|
+$25.2M |
| 3 |
Kyndryl
KD
|
+$24.4M |
| 4 |
ESCO Technologies
ESE
|
+$23.7M |
| 5 |
Cross Country Healthcare
CCRN
|
+$21.3M |
Sector Composition
| 1 | Industrials | 24.32% |
| 2 | Technology | 18.6% |
| 3 | Financials | 16.87% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Healthcare | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Helen of Troy
HELE
$550M
| $767K | 0.01% |
14,333
+8,393
| +141% | +$449K |
|
702
Synaptics
SYNA
$2.7B
| $766K | 0.01% |
12,024
-14,578
| -55% | -$929K |
|
703
Provident Financial Services
PFS
$2.58B
| $766K | 0.01% |
44,601
| – | – |
|
704
Solventum
SOLV
$12.6B
| $760K | 0.01% |
10,000
-15,000
| -60% | -$1.14M |
|
705
Scholastic
SCHL
$656M
| $754K | 0.01% |
39,951
-7,440
| -16% | -$140K |
|
706
3M
MMM
$81.5B
| $734K | 0.01% |
5,000
-6,000
| -55% | -$881K |
|
707
CorVel
CRVL
$4.49B
| $730K | 0.01% |
6,521
+2,981
| +84% | +$334K |
|
708
Eagle Bancorp
EGBN
$592M
| $702K | 0.01% |
33,437
-13,885
| -29% | -$292K |
|
709
California Resources
CRC
$4.27B
| $698K | 0.01% |
15,880
-5,406
| -25% | -$238K |
|
710
Omnicell
OMCL
$1.51B
| $679K | 0.01% |
19,417
| – | – |
|
711
Avantor
AVTR
$8.75B
| $671K | 0.01% |
+41,403
| New | +$671K |
|
712
Ball Corp
BALL
$13.7B
| $654K | 0.01% |
+12,560
| New | +$654K |
|
713
International Seaways
INSW
$2.33B
| $640K | 0.01% |
+19,287
| New | +$640K |
|
714
Robert Half
RHI
$3.65B
| $637K | 0.01% |
11,685
| – | – |
|
715
Charles River Laboratories
CRL
$7.75B
| $623K | 0.01% |
+4,140
| New | +$623K |
|
716
FS Bancorp
FSBW
$317M
| $617K | 0.01% |
+16,230
| New | +$617K |
|
717
Embecta
EMBC
$891M
| $609K | 0.01% |
47,762
-6,016
| -11% | -$76.7K |
|
718
Helmerich & Payne
HP
$1.99B
| $600K | 0.01% |
22,976
-117,747
| -84% | -$3.08M |
|
719
Protagonist Therapeutics
PTGX
$3.63B
| $593K | 0.01% |
+12,255
| New | +$593K |
|
720
Carter's
CRI
$1.05B
| $588K | 0.01% |
+14,381
| New | +$588K |
|
721
First Bancorp
FBP
$3.49B
| $581K | 0.01% |
+30,324
| New | +$581K |
|
722
Ambac
AMBC
$424M
| $579K | 0.01% |
66,122
-6,812
| -9% | -$59.6K |
|
723
WEX
WEX
$5.92B
| $578K | 0.01% |
3,680
-6,290
| -63% | -$988K |
|
724
ODP
ODP
$621M
| $575K | 0.01% |
40,157
-235,254
| -85% | -$3.37M |
|
725
First Bancorp
FBNC
$2.28B
| $562K | 0.01% |
14,000
| – | – |
|